Por: MarketWatch Business November 08, 2023
Lilly (LLY) took a direct shot at Novo on Wednesday, saying it will set a list price for Zepbound of $1,059.87 for a month’s supply, which it noted is lower than Wegovy’s list price of $1,349.02. That lower price point for Zepbound hints at a coming commercial rivalry with Novo—and the struggle to secure insurance coverage of the medicine in the U.S. Lilly shares rose 3.2% following the announcement, while Novo’s American depositary... + full article
CBS News USA Health November 08, 2023
The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its tirzepatide medication, which is branded as Mounjaro for diabetes, under a new brand for weight loss as well.While Mounjaro had already been used by some patients off-label for... + más
Eli Lilly Stock Jumps on Obesity Drug’s FDA Approval | MarketWatch
FDA approves new version of diabetes drug Mounjaro for weight loss | Los Angeles Times
MarketWatch USA Business August 08, 2023
Lilly second-quarter revenue of $8.3 billion, better than the FactSet consensus estimate of $7.6 billion. Non-GAAP earnings were $2.11 per share, better than the FactSet consensus estimate of $1.98 per share. Sales of Mounjaro, which has Food and Drug Administration approval to... + más
What Are the Duties of A Trustee? | Forbes
Rare silver coin from first Jewish revolt against Roman Empire discovered | Newsweek
WPTV USA Nation March 04, 2023
The global economic impact of obesity in 2035 is expected to be comparable to that of COVID-19 in 2020, according to a new report by the World Obesity Federation. half of the world’s population will either be considered overweight or obese by 2035. Even more concerning,... + más
Half Of Global Population Will Be Overweight In 12 Years: Study | RTTNews
‘Worrying’ global obesity projections for 2035 revealed in new report | New York Post
NBC News USA Nation March 01, 2023
Eli Lilly will cap the out-of-pocket cost of its insulin at $35 a month, the drugmaker said Wednesday. The move, experts say, could prompt other insulin makers in the U.S. to follow suit. The change, which Eli Lilly said takes effect immediately, puts the drugmaker in line with... + más
Eli Lilly plans to slash some insulin prices, expand cost cap | Orlando Sentinel
Eli Lilly plans to slash some insulin prices, expand cost cap | Portland Press Herald
NBC 6 South Florida USA World December 22, 2022
Courtesy Kristine Lilly Kristine Lilly’s whole-house Christmas decorations look good enough to eat. data-ellipsis=false> Some people go all out with — but Kristine Lilly of Kyle, Texas, gives even the brightest light displays the sweetest competition. Lilly's... + más
10 Incredible Hotel Gingerbread Displays | Forbes
America’s Most Magnificent Gingerbread Creations Are Worth A Visit | Forbes
Forbes USA Business December 15, 2022
Along the corridors of Indianapolis-based Eli Lilly, NBP may not have the brand swagger of Trulicity or Mounjaro, but as the drugmaker eyes a rich menu of growth opportunities, the sturdy acronym promises to be a powerful pain reliever. Or so Lilly CFO Anat Ashkenazi explains,... + más
Twitter was once a necessity for major brands. Under Elon Musk, it's now high risk. | CBS News
A fake tweet sparked panic at Eli Lilly and may have cost Twitter millions | Portland Press Herald
CBS News USA Politics November 15, 2022
Twitter was once the place where major brands promoted new products, responded to customer complaints and honed their image. But after less than three weeks of ownership under Elon Musk, the social media service is now viewed as high risk by one major advertising company — and... + más
How old Elon Musk was at major moments in his business career | Newsweek
Elon Musk barges into Twitter HQ as deal nears: ‘Let that sink in’ | New York Post
About iurex | Privacy Policy | Disclaimer |